MDT Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

86.780

Open

86.720

VWAP

86.12

Vol

7.34M

Mkt Cap

111.25B

Low

84.920

Amount

632.28M

EV/EBITDA(TTM)

12.95

Total Shares

1.28B

EV

129.98B

EV/OCF(TTM)

17.84

P/S(TTM)

--

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Show More

Events Timeline

(ET)

2026-03-27

09:10:00

Medtronic Receives FDA Clearance for Stealth AXiS Surgical System

2026-03-24 (ET)

2026-03-24

17:00:00

Medtronic Lowers FY2026 EPS Guidance to $5.50-$5.54

2026-03-24

08:40:00

Medtronic Enters Distribution Agreement with Merit Medical

2026-03-23 (ET)

2026-03-23

09:10:00

Medtronic Receives FDA Approval for Expanded Indication of OmniaSecure Defibrillation Lead

2026-03-19 (ET)

2026-03-19

13:20:00

Kraken Pauses IPO Plans, Quince Raises $500M

2026-03-10 (ET)

2026-03-10

07:20:00

Medtronic Enters Agreement to Acquire Scientia Vascular for $550M

2026-03-09 (ET)

2026-03-09

10:40:00

Honeywell Files Registration Statement for Aerospace Spinoff Planned in 2026

News

seekingalpha

03-31seekingalpha

MiniMed Shares Rise as Wall Street Sees Bullish Outlook Post-IPO

NASDAQ.COM

03-30NASDAQ.COM

Analysis of FNDF ETF's 52-Week Price Range

Fool

Intuitive Surgical Faces Challenges and Opportunities Ahead

seekingalpha

03-27seekingalpha

Medtronic's Robot-Assisted Surgical System Approved by FDA

NASDAQ.COM

03-27NASDAQ.COM

Medtronic's Stealth AXiS System Receives FDA Clearance

PRnewswire

03-27PRnewswire

Medtronic Launches Stealth AXiS™ Surgical System for Enhanced Precision

20 Analyst Rating

Wall Street analysts forecast MDT stock price to rise

11 Buy

9 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

102.00

Averages

111.76

High

120.00

Current: 0.000

Low

102.00

Averages

111.76

High

120.00

Mizuho

Anthony Petrone

resumed

$125

AI Analysis

2026-02-18

Reason

Mizuho

Anthony Petrone

Price Target

$125

AI Analysis

2026-02-18

resumed

Reason

Mizuho analyst Anthony Petrone resumed coverage of Medtronic with an Outperform rating and $125 price target. The firm says the company's new product launches can drive is growth higher into fiscal 2027.

JPMorgan

Robbie Marcus

Neutral

downgrade

$105 -> $100

2026-02-18

Reason

JPMorgan

Robbie Marcus

Price Target

$105 -> $100

2026-02-18

downgrade

Neutral

Reason

JPMorgan analyst Robbie Marcus lowered the firm's price target on Medtronic to $100 from $105 and keeps a Neutral rating on the shares. The firm updated the company's model.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MDT

Unlock Now

Valuation Metrics

The current forward P/E ratio for Medtronic PLC (MDT.N) is 16.41, compared to its 5-year average forward P/E of 16.88. For a more detailed relative valuation and DCF analysis to assess Medtronic PLC's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

16.88

Current PE

16.41

Overvalued PE

19.31

Undervalued PE

14.44

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

14.37

Current EV/EBITDA

13.71

Overvalued EV/EBITDA

16.27

Undervalued EV/EBITDA

12.47

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

3.73

Current PS

3.33

Overvalued PS

4.43

Undervalued PS

3.03

Financials

AI Analysis

Annual

Quarterly

Whales Holding MDT

Thornburg Investment Management, Inc.

Hardman Johnston Global Advisors LLC

Boston Partners Global Investors, Inc.

MAPFRE Asset Management

Epoch Investment Partners, Inc.

Trading Trends

People Also Watch

Frequently Asked Questions

What is Medtronic PLC (MDT) stock price today?

The current price of MDT is 86.65 USD — it has increased 1.06

What is Medtronic PLC (MDT)'s business?

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

What is the price predicton of MDT Stock?

Wall Street analysts forecast MDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MDT is111.76 USD with a low forecast of 102.00 USD and a high forecast of 120.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Medtronic PLC (MDT)'s revenue for the last quarter?

Medtronic PLC revenue for the last quarter amounts to 9.02B USD, increased 8.74

What is Medtronic PLC (MDT)'s earnings per share (EPS) for the last quarter?

Medtronic PLC. EPS for the last quarter amounts to 0.89 USD, decreased -11.88

How many employees does Medtronic PLC (MDT). have?

Medtronic PLC (MDT) has 95000 emplpoyees as of April 01 2026.

What is Medtronic PLC (MDT) market cap?

Today MDT has the market capitalization of 111.25B USD.